CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) | | |
In Millions | 9 Months Ended
Sep. 30, 2009
| 9 Months Ended
Sep. 30, 2008
|
Cash flows from operating activities: | | |
Net income | $719 | $1,114 |
Loss from discontinued operations | 5 | |
Income from continuing operations | 724 | 1,114 |
Adjustments to reconcile to net cash provided by operating activities: | | |
Depreciation, decommissioning and amortization | 1,053 | 972 |
Regulatory impacts of net nuclear decommissioning trust earnings (reflected in accumulated depreciation) | 133 | 42 |
Other amortization | 95 | 80 |
Lease terminations and other | 888 | (75) |
Stock-based compensation | 17 | 25 |
Equity in income from partnerships and unconsolidated subsidiaries - net | (34) | (40) |
Distributions and dividends from unconsolidated entities | 5 | 9 |
Deferred income taxes and investment tax credits | (1,322) | 69 |
Rent payments in excess of levelized rent expense | (161) | (162) |
Income from leveraged leases | (13) | (39) |
Long-term regulatory assets and liabilities - net | 338 | (28) |
Long-term derivative assets and liabilities - net | (176) | 29 |
Other assets | (136) | (71) |
Other liabilities | 835 | (13) |
Changes in working capital: | | |
Margin and collateral deposits - net of collateral received | (99) | (70) |
Receivables and accrued unbilled revenue | (409) | (378) |
Inventory | 4 | (75) |
Restricted cash | (148) | |
Other current assets | 190 | 93 |
Book overdrafts | 41 | 90 |
Accrued taxes | (318) | 128 |
Current regulatory assets and liabilities - net | 613 | (97) |
Current derivative assets and liabilities - net | (238) | (3) |
Accounts payable and other current liabilities | 235 | 35 |
Operating cash flows from discontinued operations | (5) | |
Net cash provided by operating activities | 2,112 | 1,635 |
Cash flows from financing activities: | | |
Long-term debt issued | 939 | 2,132 |
Long-term debt issuance costs | (25) | (15) |
Long-term debt repaid | (566) | (246) |
Bonds repurchased | (219) | (212) |
Preferred stock redeemed | | (7) |
Short-term debt financing - net | (2,058) | 1,308 |
Cash contributions from noncontrolling interests | 2 | |
Stock-based compensation - net | 4 | (22) |
Dividends and distributions to noncontrolling interests | (88) | (116) |
Dividends paid | (303) | (298) |
Net cash provided (used) by financing activities | (2,314) | 2,524 |
Cash flows from investing activities: | | |
Capital expenditures | (2,287) | (1,959) |
Purchase of interest in acquired companies | (7) | (11) |
Proceeds from termination of leases | 1,420 | |
Proceeds from sale of property and interests in projects | 1 | 113 |
Proceeds from nuclear decommissioning trust sales | 1,814 | 2,279 |
Purchases of nuclear decommissioning trust investments and other | (1,977) | (2,329) |
Proceeds from partnerships and unconsolidated subsidiaries, net of investment | 10 | 35 |
Maturities and sales of short-term investments | 3 | 80 |
Purchase of short-term investments | (1) | (22) |
Customer advances for construction and other investments | (279) | (322) |
Net cash used by investing activities | (1,303) | (2,136) |
Net increase (decrease) in cash and equivalents | (1,505) | 2,023 |
Cash and equivalents, beginning of period | 3,916 | 1,441 |
Cash and equivalents, end of period | $2,411 | $3,464 |